Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)
India · Delayed Price · Currency is INR 233.35
+0.36 (0.15%)
Sep 11, 2026, 3:30 PM IST
Jagsonpal Pharmaceuticals Market Cap
Jagsonpal Pharmaceuticals has a market cap or net worth of 15.35 billion as of September 11, 2026. Its market cap has decreased by -5.96% in one year.
Market Cap
15.35B
Enterprise Value
14.37B
Revenue
2.94B
Ranking
n/a
PE Ratio
34.75
Stock Price
233.35
ChartMarket Cap Chart
Since March 1, 2000, Jagsonpal Pharmaceuticals's market cap has decreased from 17.63B to 15.35B, a decrease of -12.91%. That is a compound annual growth rate of -0.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 15.35B | 19.37% |
| Dec 31, 2025 | 12.86B | -20.68% |
| Dec 31, 2024 | 16.22B | 58.61% |
| Dec 29, 2023 | 10.22B | 4.69% |
| Dec 30, 2022 | 9.77B | 108.36% |
| Dec 31, 2021 | 4.69B | 150.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Solara Active Pharma Sciences | 33.86B |
| Ind-Swift Laboratories | 33.77B |
| Sakar Healthcare | 25.76B |
| Windlas Biotech | 23.65B |
| Indoco Remedies | 22.55B |
| Beta Drugs | 21.60B |
| Sigachi Industries | 13.26B |
| Anlon Healthcare | 8.30B |